Australian Clinical Labs Limited

ACL.ASX

Health Care

Provision of pathology services

Market Data

Price

$2.100

+0.0%
Market Cap

$386.3M

P/E Ratio

14.2x

EPS

$0.145

Div. Yield

6.19%

52-Week Change

-0.1%

Recent Announcements

9 Jun 2026 Sph Neutral

Becoming a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.0052%).

8 May 2026 Sph Neutral

Ceasing to be a substantial holder

Franklin Resources, Inc., and its affiliates ceased to be a substantial holder.

4 May 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

27 Apr 2026 Sph Neutral

Becoming a substantial holder from MQG

MQG became a substantial holder (5.11%).

17 Apr 2026 Sph Neutral

Ceasing to be a substantial holder

United Super Pty Ltd ceased to be a substantial holder.

16 Apr 2026 Sph Neutral

Becoming a substantial holder

Australian Retirement Trust Pty LTD ATF Australian Retirement Trust became a substantial holder (5.003%).

8 Apr 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

7 Apr 2026 Sph Neutral

Becoming a substantial holder

Franklin Resources, Inc., and its affiliates became a substantial holder (5.02%).

2 Apr 2026 Sph Neutral

Becoming a substantial holder

Pinnacle Investment Management Group Limited became a substantial holder (20%).

11 Mar 2026 Sph Neutral

Becoming a substantial holder from MQG

MQG became a substantial holder (5.06%).

Get real-time alerts for ACL

Receive AI-powered earnings summaries and instant notifications when Australian Clinical Labs Limited releases results.

Register Free